Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

42.76 -2.74 (-6.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,012,330
Open 45.54
Bid (Size) 42.60 (1)
Ask (Size) 42.76 (1)
Prev. Close 45.50
Today's Range 42.00 - 45.61
52wk Range 42.00 - 120.03
Shares Outstanding 103,647,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
The Nasdaq held near 52-week highs while small caps ramped up. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 29 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-37.06%
-37.06%
1 Month
-38.93%
-38.93%
3 Month
-39.52%
-39.52%
6 Month
-45.67%
-45.67%
1 Year
-44.65%
-44.65%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
The Latest Analyst Ratings for NovoCure
Via Benzinga
Why NovoCure Stock Is Crashing Today
Via The Motley Fool
NovoCure's Return On Capital Employed Overview
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
These 2 Nasdaq Stocks Are Plunging. Here's Why
Via The Motley Fool
Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
4 Analysts Have This to Say About NovoCure
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks Mixed As VIX Extends Lows
Via Talk Markets
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Edges Higher; Joann Shares Plummet
Via Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
Via Investor's Business Daily
Dow Drops 50 Points; J.M. Smucker Earnings Top Views
Via Benzinga
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Zai Lab Limited
Via GlobeNewswire
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Novocure
Via Business Wire
Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
From Novocure
Via Business Wire
3 No-Brainer Stocks to Buy for Under $100 Right Now
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.